Related by context. All words. (Click for frequent words.) 66 sorafenib tablets 65 Seliciclib 65 Bortezomib 65 dasatinib Sprycel 64 sorafenib Nexavar 64 vorinostat 63 amrubicin 63 erlotinib Tarceva ® 63 trastuzumab Herceptin R 63 dasatinib 63 EGFR mutation 63 Zolinza 63 EGFR inhibitors 62 Doxil ® 62 Pemetrexed 62 alefacept 62 palifermin 62 VAPRISOL 62 docetaxel chemotherapy 62 K ras mutations 62 Gleevec resistant 62 dexamethasone Decadron 62 Xanafide 61 imatinib Gleevec 61 Gefitinib 61 gefitinib Iressa 61 alkylating agent 61 lapatinib Tykerb 61 talabostat 61 sulfasalazine 61 DFMO 61 erlotinib 61 Dasatinib 61 decitabine 61 Everolimus 61 pomalidomide 61 Vandetanib 61 azacytidine 61 mutated KRAS 61 fulvestrant 61 Fludara ® 61 anti angiogenic agent 61 adefovir 61 nilotinib 61 gemcitabine chemotherapy 61 DMARDS 61 FOLFOX4 61 dasatinib Sprycel ® 61 temsirolimus 61 mapatumumab 61 pegylated liposomal doxorubicin 60 pertuzumab 60 cetuximab Erbitux 60 thalidomide Thalomid 60 Hycamtin 60 FOLFOX6 60 idarubicin 60 vandetanib 60 IFN beta 60 standard chemotherapy regimen 60 nucleoside analog 60 mycophenolate mofetil 60 nucleoside analogue 60 EGFR TKI 60 clodronate 60 cetuximab Erbitux ® 60 milatuzumab 60 visilizumab 60 forskolin 60 imatinib 60 gemcitabine Gemzar 60 cediranib 60 interferon therapy 60 MGd 60 abiraterone acetate 60 trastuzumab Herceptin ® 60 5 FU leucovorin 60 anakinra 60 Gemzar ® 60 Azacitidine 60 mCRC patients 60 FUSILEV enhances 60 dacarbazine DTIC 60 imatinib therapy 60 topotecan 60 chemotherapy gemcitabine 60 NNRTIs 60 Imatinib 60 ritonavir boosted 60 anticancer therapy 60 receptor tyrosine kinase inhibitor 60 EGFr 60 mTOR inhibitor 59 tyrosine kinase inhibitors 59 erlotinib Tarceva 59 tiotropium bromide 59 APTIVUS r 59 CIMZIA ™ 59 Vidaza ® 59 tipranavir 59 complete cytogenetic response 59 leukemia CLL 59 Taxol paclitaxel 59 sorafenib 59 Amrubicin 59 iniparib 59 HGS ETR1 59 KRAS mutations 59 hydroxychloroquine 59 gemcitabine carboplatin 59 TNFa 59 LY# [003] 59 interferon ribavirin 59 fluvastatin 59 KRAS status 59 AEG# 59 PXD# 59 vinca alkaloids 59 olaparib 59 TORISEL 59 BRAF mutation 59 azacitidine 59 anti EGFR antibody 59 EFAPROXYN 59 Tarceva TM 59 TNF inhibitors 59 T#I [002] 59 Bevacizumab 59 mTOR inhibitors 59 Fulvestrant 59 Cloretazine 59 gamma secretase inhibitor 59 metastatic renal cell carcinoma 59 anti leukemic 59 adalimumab Humira 59 interferon alfa 59 dacarbazine 59 estramustine 59 docetaxel Taxotere ® 59 xanthine oxidase inhibitor 59 paricalcitol 59 pamidronate 59 intravenous bisphosphonates 59 anthracycline taxane 59 superficial bladder cancer 59 FOLFIRI 58 itraconazole 58 weekly subcutaneous injections 58 trans retinoic acid 58 neurologic progression 58 liposomal doxorubicin 58 imatinib Gleevec ® 58 cetuximab Erbitux R 58 protease inhibitor PI 58 nilotinib Tasigna ® 58 Mitoxantrone 58 pegylated interferon alpha 58 antimetabolite 58 HER2 positive metastatic breast 58 bortezomib Velcade 58 inhibitor RG# 58 HGS# 58 antiangiogenic 58 raltegravir 58 Fludara 58 Ixempra 58 biologic therapy 58 low dose cytarabine 58 melanoma tumors 58 adriamycin 58 standard chemotherapy regimens 58 low dose ritonavir 58 flutamide 58 PARP inhibitor 58 trastuzumab Herceptin 58 enzastaurin 58 Fludarabine 58 CYC# 58 chemotherapy cisplatin 58 PREZISTA r 58 relapsed MM 58 darunavir 58 Platinol ® cisplatin 58 busulfan 58 CLL cells 58 VEGF inhibitors 58 cisplatin gemcitabine 58 bicalutamide 58 oblimersen 58 leucovorin 58 EGFR tyrosine kinase inhibitors 58 angiogenesis inhibitor 58 amprenavir 58 HDAC inhibitors 58 PLX# 58 etoposide 58 PKC# 58 irinotecan doxorubicin oxaliplatin paclitaxel 58 Lenalidomide 57 TNF inhibitor 57 mRCC 57 GnRH agonists 57 alkylating agents 57 Tarceva erlotinib 57 interferon alfa 2b 57 steroid dexamethasone 57 telaprevir dosed 57 endostatin 57 Taxotere chemotherapy 57 chemoresistant 57 infusional 5-FU/LV 57 YONDELIS 57 nucleoside analogues 57 pegylated interferon alfa 57 bleomycin 57 bevacizumab Avastin 57 basal cell carcinoma BCC 57 panitumumab Vectibix 57 IGF 1R 57 tocilizumab 57 Capecitabine 57 flavopiridol 57 pegfilgrastim 57 pegylated interferon alfa 2a 57 chemoresistance 57 5 Fluorouracil 57 evaluating tivozanib 57 Erlotinib 57 Telintra 57 VELCADE melphalan 57 Peg IFN 57 MetMAb 57 leukemia AML 57 cytostatic 57 Pegasys ® 57 Velcade bortezomib 57 chemotherapeutic agents 57 xenograft models 57 Erbitux cetuximab 57 Platinol 57 Irinotecan 57 dosage regimens 57 entecavir 57 liposomal formulation 57 DMARDs 57 EGFR TKIs 57 peginterferon 57 Tumor Necrosis Factor 57 taxane chemotherapy 57 endoxifen 57 DOXIL 57 Flu Cy 57 daunorubicin 57 bevacizumab Avastin ® 57 chemotherapeutic drug 57 histone deacetylase inhibitor 57 vinorelbine 57 sustained virological response 57 olmesartan 57 CIMZIA TM 57 Navelbine 57 molecularly targeted 57 CA4P 57 dexrazoxane 57 Copegus ribavirin 57 microtubule targeting 57 ALIMTA cisplatin 57 prednisone prednisolone 57 tyrosine kinase inhibitor 57 refractory NSCLC 57 ELOXATIN 57 metastatic lung cancer 57 nelfinavir 57 TNF antagonist 57 octreotide LAR 56 Torisel 56 surrogate endpoint 56 cis retinoic acid 56 FOLFIRINOX 56 paclitaxel Taxol 56 mTOR mammalian target 56 Preclinical studies 56 Gemcitabine 56 leflunomide 56 gastrointestinal stromal tumors 56 peg IFN 56 gemcitabine Gemzar ® 56 temozolomide 56 unresectable stage 56 alpha interferons 56 axitinib 56 fluoropyrimidine 56 IMC A# 56 relapsed ovarian cancer 56 alpha interferon 56 BMS # 56 cyclophosphamide Cytoxan 56 VIDAZA 56 teriparatide 56 APTIVUS 56 Doxil 56 TTF Therapy 56 lenalidomide dexamethasone 56 docetaxel Taxotere 56 KRAS mutant tumors 56 HER2 receptor 56 Aptivus ® 56 bortezomib Velcade R 56 nitazoxanide 56 zoledronate 56 interferon IFN 56 lenalidomide Revlimid R 56 viral kinetics 56 anti TNF 56 oral clodronate 56 adalimumab 56 trabectedin 56 Imprime PGG 56 isoproterenol 56 gemcitabine cisplatin 56 Peginterferon 56 epithelial tumors 56 IGFBP 3 56 BCG refractory 56 recurrent glioblastoma multiforme 56 antiandrogen 56 panitumumab 56 sorafenib Nexavar ® 56 intravenous cyclophosphamide 56 hematologic toxicity 56 etanercept 56 immunomodulator 56 Taxol ® 56 squamous histology 56 KIT mutations 56 anticancer agents 56 cilengitide 56 PREZISTA rtv 56 INTELENCE 56 cabazitaxel 56 cell lymphoma CTCL 56 chemotherapeutic drugs 56 TNFα 56 TYKERB 56 nab paclitaxel 56 Fluorouracil 56 fosamprenavir 56 Cytarabine 56 bendamustine 56 G CSF 56 bortezomib 56 sunitinib 56 liver metastases 56 plus prednisone 56 Degarelix 55 proteasome inhibitors 55 Herceptin trastuzumab 55 alfa 2a 55 gefitinib 55 bevacizumab Avastin R 55 intravesical instillation 55 cisplatin chemotherapy 55 piperacillin tazobactam 55 recurrent NSCLC 55 mg kg dose 55 Xelox 55 PARP inhibitors 55 interferon alfa 2a 55 lopinavir 55 erythropoietic 55 TKIs 55 fludarabine 55 PI3K inhibitor 55 depsipeptide 55 idraparinux 55 colorectal carcinoma 55 interferon beta 55 endocrine therapies 55 tegafur 55 vinca alkaloid 55 paclitaxel cisplatin 55 follicular lymphoma FL 55 abacavir lamivudine 55 PSMA ADC 55 mutated KRAS gene 55 Paraplatin ® carboplatin 55 Lapatinib 55 CANCIDAS 55 cidofovir 55 metastatic colorectal 55 5-FU/LV 55 stage IIIb IV 55 Vidofludimus 55 taxol 55 denileukin diftitox 55 mitoxantrone 55 Pharmacokinetics PK 55 amphotericin B 55 Folfox 55 corticosteroid dexamethasone 55 TRAIL induced apoptosis 55 DAPT 55 pegylated 55 capecitabine Xeloda 55 protease inhibitor 55 tenofovir Viread 55 Doxorubicin 55 anti mitotic 55 CHOP chemotherapy 55 Vectibix 55 anti androgen 55 chemotherapy FOLFOX 55 proteasome inhibitor bortezomib 55 comparator arm 55 neoadjuvant chemotherapy 55 NRTIs 55 Mylotarg 55 nucleoside reverse transcriptase inhibitor 55 cisplatin 55 ixabepilone 55 paclitaxel Taxol ® 55 chlorambucil 55 trastuzumab 55 aromatase inhibitor 55 gemcitabine 55 active comparator 55 biochemical relapse 55 docetaxel Taxotere R 55 interferon alpha 55 trans retinoic acid ATRA 55 dalteparin 55 imetelstat 55 recurrent glioblastoma 55 plus dexamethasone 55 Platinol ® 55 ribavirin RBV 55 Interferon alfa 55 Alemtuzumab 55 immunosuppressive agents 55 letrozole Femara 55 Etoposide 55 prostate carcinoma 55 sirolimus 55 Proxinium TM 55 Topotecan 55 LHRH 55 antitumor activity 55 apoptotic pathway 55 Cremophor 55 GRN#L 55 recurrent GBM 55 taxane therapy 55 androgen deprivation 54 pyridostigmine 54 IFN alpha 54 plus gemcitabine 54 uric acid lowering 54 factor G CSF 54 dacarbazine chemotherapy 54 lapatinib 54 Cisplatin 54 palliative radiotherapy 54 Pegasys peginterferon alfa 2a 54 pyrazinamide 54 teriflunomide 54 cetuximab 54 IV bisphosphonates 54 heavily pretreated 54 metastatic malignant 54 NMIBC 54 tenofovir emtricitabine 54 Exemestane 54 Temozolomide 54 CTLA 4 54 6 mercaptopurine 54 Trastuzumab 54 farletuzumab 54 cyclophosphamide chemotherapy 54 5FU 54 insulin glargine 54 Taxotere docetaxel 54 abiraterone 54 cardiac toxicity 54 placebo dexamethasone 54 PC3 cells 54 pCR 54 imipenem 54 glatiramer acetate 54 severe neutropenia 54 clopidogrel Plavix 54 cisplatin resistant 54 Voreloxin 54 LHRH receptor positive 54 multikinase inhibitor 54 saline placebo 54 Docetaxel 54 aprepitant 54 OPAXIO 54 recombinant erythropoietin 54 anastrozole 54 Bleomycin 54 chemotherapeutic agent 54 Xcytrin 54 administered subcutaneously 54 SCH # 54 irinotecan chemotherapy 54 chemotherapeutic regimens 54 lung metastases 54 bezafibrate 54 ethambutol 54 Paraplatin ® 54 PegIFN RBV 54 rFSH 54 biologic DMARD 54 cyclin E 54 tumor recurrence 54 tamoxifen therapy 54 immunosuppressant 54 adjuvant cisplatin 54 rituximab Rituxan 54 fallopian tube cancers 54 antitumor effects 54 Akt activation 54 Bcl xL 54 pioglitazone 54 transgene expression 54 IFN α 54 AKT inhibitor 54 fondaparinux 54 Sorafenib 53 antitumor effect 53 nonsmall cell lung cancer 53 allogeneic SCT 53 calcitriol 53 Combination therapy 53 postoperative chemotherapy 53 heavily pretreated patients 53 Camptosar ® 53 antiangiogenic therapy 53 Chemophase 53 LEXIVA r 53 relapsed SCLC 53 TNF α 53 hepatic metastases 53 5 FU 53 seliciclib 53 lamivudine 53 adjuvant radiotherapy 53 Neoadjuvant 53 Gemzar gemcitabine 53 resectable 53 conventional DMARDs 53 Pegylated Interferon 53 eribulin 53 sulfonylurea 53 FOLPI 53 pemetrexed 53 methotrexate therapy 53 Anthracycline 53 chemotherapeutics 53 tyrosine kinase inhibitors TKIs 53 EGF receptor 53 immunosuppressive 53 XELOX 53 azathioprine 53 complete cytogenetic 53 Cytoxan 53 splenectomized patients 53 FK# 53 FOLFOX 53 metastatic relapsed 53 anti proliferative 53 interferon 53 cytotoxic agents 53 neoadjuvant therapy 53 irinotecan 53 colon carcinoma 53 meropenem 53 L dopa 53 Vincristine 53 Decitabine 53 phenoxodiol 53 raloxifene Evista 53 hormonal therapies 53 fibrinolytic 53 EGFR 53 peginterferon alfa 2a 53 Ceplene/IL-2 53 cyclophosphamide doxorubicin vincristine 53 ISF# 53 hydralazine 53 stage IIIB 53 grade gliomas 53 vincristine doxorubicin 53 bone metastasis 53 pancreatic adenocarcinoma 53 Rituximab 53 carboplatin paclitaxel 53 rituximab 53 tacrolimus ointment 53 doxorubicin HCl liposome injection 53 goserelin 53 glioma cells 53 ganciclovir 53 Halaven 53 NSCLC 53 GEMZAR 53 glargine 53 monotherapy 53 metastatic RCC 53 PGE2 53 interferons 53 anticancer agent 53 PSADT 53 GISTs 53 radiochemotherapy 53 docetaxel 53 WT1 53 potentially hepatotoxic 53 infliximab 53 Tykerb 53 refractory AML 53 vancomycin 53 tamsulosin 53 cyclophosphamide 53 ALIMTA 53 panobinostat 52 zoledronic acid 52 tumor shrinkage 52 granisetron 52 partial remissions 52 exemestane 52 peritoneal carcinomatosis 52 5 fluorouracil leucovorin 52 irbesartan 52 sevelamer 52 NRTI 52 8mg/kg 52 papillary renal cell carcinoma 52 mitoxantrone chemotherapy 52 taxanes 52 taxane 52 FOLFOX chemotherapy 52 chemoembolization 52 recurrent metastatic 52 microtubule inhibitor 52 Methotrexate 52 adjuvant tamoxifen 52 receiving VICTRELIS 52 chemotherapy regimens 52 melphalan prednisone 52 Trabectedin 52 myeloablative 52 SCCHN 52 vinblastine 52 advanced NSCLC 52 neuroblastoma cells 52 Taxotere ® 52 voriconazole 52 ERCC1 52 EGFR expressing 52 Alkeran 52 fluorouracil 52 EUS FNA 52 retinoid 52 peginterferon alfa 2b 52 paclitaxel chemotherapy 52 ALA PDT 52 rapamycin 52 overlapping toxicities 52 FluCAM 52 anthracycline chemotherapy 52 Cetuximab 52 inhibitory effects 52 cytotoxic therapy 52 sunitinib malate 52 PegIFN 52 oxaliplatin 52 octreotide 52 platelet inhibitor 52 HER2 negative 52 Mitomycin C 52 Telcyta 52 cyclophosphamide methotrexate 52 fallopian tube carcinoma 52 fluconazole 52 carboplatin 52 Ontak 52 antitumor 52 prostate cancer AIPC 52 epirubicin 52 concurrent chemoradiation 52 DMARD 52 levodopa 52 capecitabine Xeloda R 52 PD LID 52 intravesical 52 bladder cancers 52 lopinavir r 52 Rituxan rituximab 52 HER2 positive 52 preoperative chemotherapy 52 Tarceva 52 EpCAM 52 camptothecin 51 Zoledronic acid 51 ifosfamide 51 virologic response 51 antihypertensive therapy 51 adjuvant radiation 51 4mg/kg 51 cytarabine daunorubicin 51 antithymocyte globulin 51 intradermal injection 51 VICTRELIS 51 hepatocellular carcinoma HCC 51 docetaxel prednisone 51 methotrexate 51 paclitaxel Taxol R 51 indomethacin 51 eribulin mesylate 51 NNRTI 51 chemoradiation therapy 51 LMWH 51 adecatumumab 51 Celecoxib 51 luteinizing hormone releasing 51 cisplatin carboplatin 51 chemotherapies 51 cytarabine 51 LHRH agonists 51 FOLFIRI alone 51 colorectal cancer liver metastases 51 mcg kg 51 5 fluorouracil 51 relapsing multiple sclerosis 51 taxotere 51 cyclosporin 51 allopurinol 51 CsA 51 Adjuvant chemotherapy 51 beclomethasone dipropionate 51 poly ADP ribose polymerase 51 urothelial cancer 51 atazanavir 51 NF kappaB activation 51 zalutumumab 51 iNOS 51 micrometastases 51 paclitaxel 51 chemotherapy docetaxel 51 temozolomide Temodar 51 mitomycin 51 colorectal liver metastases 51 darunavir ritonavir 51 oral allopurinol 51 rifampicin 51 mg/m2 dose 51 plus 5-FU/LV 51 EGFR expressing mCRC 51 ibandronate 51 3TC lamivudine Epivir 51 metastatic disease 51 metastatic tumors 51 ERBB2 51 metastatic malignant melanoma 51 mesothelin 51 TAXOTERE R 51 nucleoside reverse transcriptase inhibitors 51 metformin 51 refractory ovarian cancer 51 dose cytarabine 51 captopril 51 pegylated interferon 51 metastatic colorectal carcinoma 51 tamoxifen 51 cytoreductive surgery 51 HDACi 51 mitomycin C 50 peg interferon 50 ceftriaxone 50 recurrent ovarian cancer 50 chemotherapeutic regimen 50 topoisomerase 50 Revlimid lenalidomide 50 N acetylcysteine 50 xenograft tumors 50 radiation chemoradiation 50 IMGN# 50 remission induction 50 chronic lymphocytic leukemia CLL 50 adjuvant therapy 50 lenalidomide 50 intravenous dosing 50 T DM1 50 doxorubicin 50 bevacizumab 50 disease progression 50 Neulasta ® 50 relapsed CLL 50 darunavir r 50 anthracyclines 50 Faslodex 50 ritonavir 50 celecoxib 50 TACE 50 Carboplatin 50 dexamethasone 50 nonmetastatic 50 peginterferon alpha 2a 50 DOXIL ® 50 sorafenib Nexavar R 50 tiotropium 50 dose melphalan 50 mycophenolate mofetil MMF 50 efavirenz EFV 50 virologic failure 50 plus ribavirin 50 GnRH agonist 50 glucocorticoids 50 ISTODAX 50 tumor progression 50 epirubicin cyclophosphamide 50 BEACOPP 50 doxorubicin Adriamycin 50 interferon beta 1a 49 PC# cells 49 tumors 49 tinidazole 49 locoregional recurrence 49 lung tumors 49 Pegasys plus Copegus 49 LHRH agonist 49 intravenously administered 49 rhGH 49 cytotoxic chemotherapy 49 glioblastoma multiforme GBM 49 Camptosar ® irinotecan 49 unresectable 49 overexpression 49 anthracycline 49 estrogen receptor 49 low dose dexamethasone 49 nonmyeloablative 49 neoadjuvant 49 degarelix 49 brain metastases 49 dose dexamethasone 49 chemoradiotherapy 49 methotrexate MTX 49 free survival PFS 49 Oxaliplatin 49 external beam radiotherapy 49 unfractionated heparin 49 cranial radiation 49 radiotherapy RT 49 Xeloda 49 androgen deprivation therapy 49 induces apoptosis 49 follicular NHL 49 distant metastases 49 metastatic colorectal cancer 49 Taxotere 49 GM CSF 49 Epirubicin 49 microwave hyperthermia 49 mg m² 49 anastrazole 49 pazopanib 49 median PFS 49 chemotherapeutic 49 Paclitaxel 49 paclitaxel poliglumex 48 metastatic colon cancer 48 dose regimens 48 resistant ovarian cancer 48 active metabolite 48 abciximab 48 adjuvant chemotherapy 48 intratumoral injection 48 HER2 positive tumors 48 metastatic NSCLC 48 HER2 48 Taxotere R 48 STAT3 48 arsenic trioxide 48 tumor cells 48 administered orally 48 MDM2 48 solid tumors 48 metastatic prostate cancer 48 survivin 48 Cyclophosphamide 48 ERBITUX 48 ABVD 48 pentamidine 48 melphalan 48 EBRT 48 febrile neutropenia 48 chemotherapy regimen 48 anticancer drugs 48 radiofrequency ablation RFA 48 Camptothecin 48 induced apoptosis 48 grade glioma 48 subcutaneous SC 48 locoregional 48 isoniazid 48 antiretroviral regimens 48 advanced unresectable 48 rhTSH 48 chemoradiation 48 cytotoxicity 48 cytoreduction 48 DLBCL 48 Interferon 48 relapsed refractory 48 capecitabine 48 #mg/m# [002] 48 injected subcutaneously 48 chemo radiotherapy 48 zidovudine 48 epirubicin cisplatin 48 neoadjuvant treatment 47 platinum refractory 47 glucocorticoid 47 Ribavirin 47 temozolomide TMZ 47 doxorubicin cyclophosphamide 47 dose clopidogrel 47 Toxicities 47 receiving highly emetogenic 47 clopidogrel 47 #mg/m# [001] 47 breast carcinoma 47 metastases 47 paclitaxel carboplatin 47 Tamoxifen 47 letrozole 47 advanced hepatocellular carcinoma 47 clomiphene 47 androgen suppression 47 bone metastases 47 metastatic 47 fluorouracil leucovorin 47 xenografts 46 lymphomas 46 intramuscularly 46 tumor regression 46 pegylated interferon alfa 2b 46 Taxol 46 hormone receptor positive 46 operable breast cancer 46 HER2 positive breast cancer 46 autologous transplants 46 cyclin D1 46 endocrine therapy 46 cytotoxic 46 DMARD therapy 46 HER2 + 46 conventional chemotherapies 46 neurotoxicity 46 distant metastasis 45 cell lung cancer 45 transfected 45 ototoxicity 45 corticosteroids 45 dose interleukin 45 toxicities 45 doxorubicin docetaxel 45 surgical debulking 45 Adriamycin 45 #mg/kg [002] 45 adjuvant 45 hormonal therapy 45 mCRC 45 axillary lymph node dissection 44 cystectomy 44 invasive bladder 44 androgen blockade 44 intravenous infusions 44 intraperitoneal injection 44 ribavirin 44 mg/m2 43 metastatic breast cancer 43 administered intravenously 43 medroxyprogesterone acetate 43 vincristine 42 ASCT 42 3TC 42 dose cyclophosphamide 41 Herceptin 41 WBRT 40 carcinoma 40 chemotherapy 38 Chemotherapy 34 radiation therapy 31 radiotherapy 30 chemo